Ocupress

Active Ingredient(s): Carteolol
FDA Approved: * May 23, 1990
Pharm Company: * NOVARTIS
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ocupress Overview

Carteolol is a non-selective beta blocker used to treat glaucoma. It has been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.[1] It was patented in 1972 and approved for medical use in 1980.[2] Brand names Brand names include Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, and Singlauc. References...

Read more Ocupress Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carteolol

Recent Ocupress Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Carteolol
  • Solution: 1%
  • Solution/drops: 1%
  • Tablet: 10mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Carteolol or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA